Kala Pharmaceuticals Inc Total Liabilities

Latest as of March 2026: $2.49 Million USD

Kala Pharmaceuticals Inc total liabilities. Based on the latest financial reports, Kala Pharmaceuticals Inc (KALA) has total liabilities worth $2.49 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Kala Pharmaceuticals Inc's assets to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Kala Pharmaceuticals Inc (2013–2025)

Total liabilities of Kala Pharmaceuticals Inc from 2013 to 2025. This chart illustrates how Kala Pharmaceuticals Inc's total liabilities have evolved over time, based on quarterly financial data.

Kala Pharmaceuticals Inc Competitors by Total Liabilities

The table below lists competitors of Kala Pharmaceuticals Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Petrotal Corp LSE:PTAL	UK	GBX261.47 Million
Bekasi Asri Pemula Tbk JK:BAPA	Indonesia	Rp17.32 Billion
Springs Global Participações S.A. SA:SGPS3	Brazil	R$3.26 Billion
Pacific Strategic Financial JK:APIC	Indonesia	Rp4.41 Trillion
Fidelity Japanese Values PLC ORD LSE:FJV	UK	GBX2.64 Million
PT Trimuda Nuansa Citra Tbk JK:TNCA	Indonesia	Rp17.20 Billion
Knosys Ltd AU:KNO	Australia	AU$8.90 Million
Omnia Metals Group Ltd AU:OM1	Australia	AU$276.32K

Liability Composition Analysis (2013–2025)

This chart breaks down Kala Pharmaceuticals Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Kala Pharmaceuticals Inc.

Liquidity & Leverage Metrics

Kala Pharmaceuticals Inc Total Liabilities Ratios Explained

Kala Pharmaceuticals Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.81	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kala Pharmaceuticals Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kala Pharmaceuticals Inc (2013–2025)

The table below shows the annual total liabilities of Kala Pharmaceuticals Inc from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	$2.49 Million	-94.22%
2024-12-31	$43.15 Million	-10.93%
2023-12-31	$48.45 Million	-28.60%
2022-12-31	$67.85 Million	-44.67%
2021-12-31	$122.62 Million	+0.83%
2020-12-31	$121.61 Million	-2.42%
2019-12-31	$124.63 Million	+7.46%
2018-12-31	$115.98 Million	+338.42%
2017-12-31	$26.45 Million	-80.27%
2016-12-31	$134.09 Million	+841.58%
2015-12-31	$14.24 Million	+68.33%
2014-12-31	$8.46 Million	+23.14%
2013-12-31	$6.87 Million	--

About Kala Pharmaceuticals Inc

NASDAQ:KALA USA Biotechnology

Market Cap

$3.22 Million

Market Cap Rank

#29350 Global

#6009 in USA

Share Price

$0.17

Change (1 day)

+3.47%

52-Week Range

$0.08 - $3.91

All Time High

$1326.50